N. Sodeyama et al., DEVELOPMENTAL-CHANGES OF SIALYLATION OF SOLUBLE BETA A4 AMYLOID PROTEIN-PRECURSOR DERIVATIVES IN HUMAN CEREBROSPINAL-FLUID/, Molecular brain research, 27(2), 1994, pp. 320-322
Soluble beta/A4 amyloid protein precursor derivatives (APPs) in cerebr
ospinal fluid from infants, children, adults and aged individuals were
treated with neuraminidase. In the samples from infants, reduction of
molecular weight of APPs following neuraminidase treatment was signif
icantly less than those from adults or aged individuals. Hyposialylati
on of beta/A4 amyloid protein precursor in infants may be relevant to
a physiological role of this molecule in the development of the nervou
s system.